期刊文献+

SULT1A1蛋白表达和性激素含量与子宫肌瘤发病相关性的研究 被引量:13

Correlation research on the expression of SULT1A1,contents of sex hormone and pathogenesis hysteromyoma
在线阅读 下载PDF
导出
摘要 目的:检测子宫肌瘤SULT1A1蛋白表达和性激素含量,分析其在子宫肌瘤发生、发展中的作用。方法:化学发光分析法测定30例子宫肌瘤患者、30例同年龄段健康女性以及10例因CINⅢ行全子宫切除术患者血清及组织匀浆中E2、P、T含量。Western Blot方法检测SULT1A1蛋白的表达,并采用Spearman进行等级相关分析。结果:肌瘤组血清E2含量明显低于健康女性组(P<0.05),其T含量则明显高于健康女性组(P<0.01),P含量各组无显著差异。肌瘤组织E2含量显著高于肌瘤包膜外子宫肌层组织及CINⅢ患者子宫肌层组织(P<0.001)、前二者P、T含量组间无显著差异。肌瘤组织中SULT1A1蛋白表达与肌瘤包膜外子宫肌层组织比较差异显著(P<0.05)。肌瘤组织,肌瘤包膜外子宫肌层组织和CINⅢ患者子宫肌层组织中SULT1A1蛋白相对含量与相应组织匀浆E2含量均为负相关,与相应血清E2含量无明显相关性。结论:子宫肌瘤的发生、发展与子宫肌瘤组织局部SULT1A1蛋白活性降低有关。 Objectlve:To detect the expression of SULT1A1 and the eonents of sex horlnone,to analyse the rela- tionship of SULT1A1 and sex hormone in the occurrence and development of hysterolnyolna. Methods:The expres- sions of estradiol ( E2), progesterone ( P ) and testosterone (T) in sermn and tissue of 30 patients with hysterolnyolna, 10 patients with CIN Ⅲ and 30 healthy women in the same age were measured with chemiluminescence analysis. The Western Blot was used to detect the expression of SULT1A1 and the spearman was used to analyse the rank eorrda- tion. Results:The sermn E2 of study group was significantly lower than that of control group(P 〈0.01). The hystero- myoma E2 levels were significantly higher than those of normal hysteromyoma tissue of study group and CIN Ⅲ ( P 〈 0. 001). The difference of SULT1A1 expression in hysteromyoma and normal uterine tissue was significant ;The relationship of SULT1A1 relative contents in tissues including hysteromyoma and normal uterine tissues and tissues E2 was negativdy eorrdated,but was no correlation with serum E2. Conclusion:The lower SULT1A1 in local uterine tis- sue may play important role in the occurrence and development of hysteromyom.
出处 《现代肿瘤医学》 CAS 2014年第3期615-618,共4页 Journal of Modern Oncology
关键词 子宫肌瘤 SULT1A1蛋白 性激素 硫酸基转移酶 hysterolnyolna SULT1A1 sex hormone SULTs
作者简介 曹荣(1986-),女,内蒙古人,硕士,医师,主要从事妇科临床诊治工作。E-mail:caorong105@163.com 【通讯作者】王敏(1963-),女,辽宁大连人,教授,主任医师,主要从事妇产科医疗、教学与科研工作。E-mail:wm21st@126.com
  • 相关文献

参考文献9

二级参考文献99

  • 1董丽霞,濮德敏.子宫肌瘤发病机制研究进展[J].中国妇产科临床杂志,2001,2(5):311-313. 被引量:7
  • 2尚丽新,张忠福,王德智,鲁海欧,潘用宾,黄华芬.子宫肌瘤患者血清性激素水平的变化[J].中华妇产科杂志,1995,30(4):233-234. 被引量:164
  • 3姜卫国.黄体酮:在子宫肌瘤发生机理中的重要作用[J].国外医学(妇产科学分册),1996,23(2):95-96. 被引量:28
  • 4曹泽毅.中华妇产科学[M].北京:人民卫生出版社,2000,1.1224-1230.
  • 5Wang M,Ebmeier CC,Olin JR,et al.Sulfation of tibolone metabolites by human postmenopausal liver and small intestinal sulfotransferases (SULTs)[J].Steroids,2006,71 (5):343-351.
  • 6Ung D,Nagar S.Trans-resveratrol-mediated inhibition of beta-oestradiol conjugation in MCF-7 cells stably expressing human sulfotransferases SULT1A1 or SULT1E1,and human liver microsomes[J].Xenobiotica,2009,39(1):72-79.
  • 7Bulun SE,Simpson ER,Word RA.Expression of the CYP19 gene and its pruduct aromatase cytochrome P450 in human uterine leiomyoma tissues and cells in culture[J].Clin Endocrinol Metab,1994,78(3):736-743.
  • 8Hirata H,Hinoda Y,Okayama N,et al.CYP1A1,SULT1A1,and SULT1E1 polymorphisms are risk factors for endometrial cancer susceptibility[J].Cancer,2008,112(9):1964-1973.
  • 9Ji-Yeob Choi,Kyoung-Mu Lee,Sue Kyung Park.Genetic polymorphisms of SULT1A1 and SULT1E1 and the risk and survival of breast cancer[J].Cancer Epidemiol Biomarkers & Prevent,2006,14(5):1074-1095.
  • 10Shozu M,Murakami K,Inoue M.Aromatase and leiomyoma of the uterus[J].Semin Reprod Med,2004,22(1):51-60.

共引文献30

同被引文献111

  • 1杨蕾,秦占芬,蒋湘宁,徐晓白.雌激素致乳腺癌机制的研究进展[J].肿瘤防治研究,2006,33(11):840-842. 被引量:7
  • 2郑姣,周宏灏.黄酮类化合物对细胞色素P450 CYP1,2E1,3A4和19的影响[J].药学学报,2007,42(1):8-12. 被引量:27
  • 3王敏,王静云,王欣彦,谭卓毅,何旖旎,岳阳.硫酸基转移酶基因在正常子宫内膜组织中的表达及意义[J].中华妇产科杂志,2007,42(10):708-710. 被引量:4
  • 4Brandon DD,Erickson TE,Keenan EJ,et al.Estrogen receptor gene expression in human uterine myomas[J].Am J Obstet Gynecol,1995,14(3):770-772.
  • 5Zaslawski R,Surowiak P,Dziegiel P,et al.Analysis of the expression of estrogen and progesterone receptors,and of PC-NA and Ki-67 proliferation antigens,in uterine myomata cells in relation to the phase of the menstrual cycle[J].Med Sci Monit,2001,7(5):908-913.
  • 6Chen L,Yang B.Immunohistochemical analysis of p16,p53,and Ki-67 expression in uterine smooth muscle tumors[J].Int J Gynecol Pathol,2008,27 (3):326-332.
  • 7Marzenna N,Ewa S,Anna N,et al.The effect of cadmium on steroid hormones and their receptors in women with uterine myomas[J].Arch Environ Cont-ain Toxicol,2011,60(4):734-741.
  • 8Hummel CW,Geiser AG,Bryant HU,et al.A selective estrogen receptor modulator designed for the treatment of uterineleiomyoma with unique tissue specificity for uterus and ovariesin rats[J].J Med Chem,2005,48(22):6772-6775.
  • 9Cook JD,Walker CL.Treatment strategies for uterine leiomyoma:the role of hormonal modulation[J].Semin Reprod Med,2004,22(2):105-111.
  • 10Grings AO,Lora V,Ferreira GD,et al.Protein expression of estrogen receptors a and p and aromatase in myometrium anduterine leiomyoma[J].Gynecol Obstet Invest,2012,73(2):113-117.

引证文献13

二级引证文献65

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部